Keywords: celexa, driving, lundbeck, profits, danish, drugmaker, posted
Celexa driving Lundbeck profits
Article | 18 August 1999
Danish drugmaker H Lundbeck has posted first-half 1999 pretax profits of517 million Danish kroner ($73.5 million), up 66%, while sales went up 26% to 1.9 ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- SciClone gains China rights to Zensun's Neucardin
